1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
- Contribution to journal › Article
- 2019
-
Mark
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
- Contribution to journal › Article